- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
PharmaEssentia
Market Cap: NT$181.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$490.50
7D
1.2%
1Y
-19.6%
Lotus Pharmaceutical
Market Cap: NT$73.1b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$278.00
7D
-2.5%
1Y
3.3%
Bora Pharmaceuticals
Market Cap: NT$59.5b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$480.00
7D
-3.4%
1Y
-23.8%